These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 16565690)

  • 1. [Metabolic syndrome: current issues and perspectives].
    Calò LA; Cosentino F; De Luca N
    Minerva Med; 2006 Feb; 97(1):1-3. PubMed ID: 16565690
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolic syndrome: current issues and perspectives.
    Calò LA; Cosentino F; De Luca N
    Panminerva Med; 2006 Mar; 48(1):1-2. PubMed ID: 16633325
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cardiovascular risk and metabolic syndrome in youth: Canadian perspectives].
    Lambert M
    Arch Pediatr; 2009 Jun; 16(6):689-91. PubMed ID: 19541131
    [No Abstract]   [Full Text] [Related]  

  • 4. New insights into understanding cardiometabolic risk. Introduction.
    Fonarow GC; Watson KE
    Rev Cardiovasc Med; 2007; 8 Suppl 4():S1-2. PubMed ID: 17934389
    [No Abstract]   [Full Text] [Related]  

  • 5. Importance of diagnosing and treating the metabolic syndrome in reducing cardiovascular risk.
    Smith SR
    Obesity (Silver Spring); 2006 Jun; 14 Suppl 3():128S-134S. PubMed ID: 16931494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of hypertension and other cardiovascular risk factors in patients with metabolic syndrome.
    Suzuki T; Homma S
    Med Clin North Am; 2007 Nov; 91(6):1211-23, x. PubMed ID: 17964917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prehypertension and metabolic syndrome: prevention of hypertension and cardiovascular events.
    Matsuura H
    Hypertens Res; 2008 Jul; 31(7):1275-6. PubMed ID: 18957794
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiovascular morbidity and mortality of the metabolic syndrome.
    Obunai K; Jani S; Dangas GD
    Med Clin North Am; 2007 Nov; 91(6):1169-84, x. PubMed ID: 17964915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic syndrome and cardiovascular disease.
    Waspadji S
    Acta Med Indones; 2006; 38(4):177-8. PubMed ID: 17175608
    [No Abstract]   [Full Text] [Related]  

  • 10. Does the metabolic syndrome add to the diagnosis and treatment of cardiovascular disease?
    de Zeeuw D; Bakker SJ
    Nat Clin Pract Cardiovasc Med; 2008 Jul; 5 Suppl 1():S10-4. PubMed ID: 18580860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin receptor blockers: Cardiovascular protection in the metabolic syndrome.
    Deedwania PC; Schmieder R
    J Renin Angiotensin Aldosterone Syst; 2006 Jun; 7 Suppl 1():S12-8. PubMed ID: 16986230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic syndrome: to be or not to be?
    Laakso M; Kovanen PT
    Ann Med; 2006; 38(1):32-3. PubMed ID: 16448986
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cardiovascular risk associated with obesity and metabolic syndrome: the European point of view].
    Tounian P
    Arch Pediatr; 2009 Jun; 16(6):687-8. PubMed ID: 19541130
    [No Abstract]   [Full Text] [Related]  

  • 14. Metabolic syndrome, diabetes and cardiovascular events: current controversies and recommendations.
    Zarich SW
    Minerva Cardioangiol; 2006 Apr; 54(2):195-214. PubMed ID: 16778752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The metabolic syndrome and cardiovascular disease: part 2.
    Jiamsripong P; Mookadam M; Alharthi MS; Khandheria BK; Mookadam F
    Prev Cardiol; 2008; 11(4):223-9. PubMed ID: 19476575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular risk and adrenergic overdrive in the metabolic syndrome.
    Grassi G; Quarti-Trevano F; Seravalle G; Dell'Oro R
    Nutr Metab Cardiovasc Dis; 2007 Jul; 17(6):473-81. PubMed ID: 17451923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic syndrome: is it a syndrome? Does it matter?
    Kahn R
    Circulation; 2007 Apr; 115(13):1806-10; discussion 1811. PubMed ID: 17404171
    [No Abstract]   [Full Text] [Related]  

  • 18. Relationship between the metabolic syndrome and the development of hypertension in the Hong Kong Cardiovascular Risk Factor Prevalence Study-2 (CRISPS2).
    Cheung BM; Wat NM; Man YB; Tam S; Cheng CH; Leung GM; Woo J; Janus ED; Lau CP; Lam TH; Lam KS
    Am J Hypertens; 2008 Jan; 21(1):17-22. PubMed ID: 18091739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solvay addresses unmet needs in the management of hypertensive patients with cardiometabolic and lipid disorders.
    Cardiovasc J Afr; 2009; 20(1):73-4. PubMed ID: 19287821
    [No Abstract]   [Full Text] [Related]  

  • 20. Is the concept of 'cardiometabolic risk' more useful than 'metabolic syndrome'?
    Koshiyama H; Taniguchi A; Inagaki N; Seino Y
    Diabet Med; 2007 May; 24(5):571. PubMed ID: 17470194
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.